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ABSTRACT 25 
This work represents an investigation into the presence, abundance and diversity of 26 
virus-like particles (VLPs) associated with human faecal and caecal samples. Various 27 
methodologies for the recovery of VLPs from faeces were tested and optimized, including 28 
successful down-stream processing of such samples for the purpose of an in-depth electron 29 
microscopic analysis, pulsed-field gel electrophoresis and efficient DNA recovery. The 30 
applicability of the developed VLP characterization method beyond the use of faecal samples 31 
was then verified using samples obtained from human caecal fluid. 32 
 33 
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1. INTRODUCTION 39 
Viruses are the most numerous biological entities within the biosphere of our planet 40 
(being present at an estimated number of ~1031), with bacteriophages representing the most 41 
abundant group of environmental viruses [1, 2]. Bacteriophages are ubiquitous viruses that 42 
infect bacterial cells and disrupt their metabolism. Multiple bacteriophage types can infect a 43 
specific microbial isolate, with most bacteriophages infecting only certain species or even 44 
strains of bacteria [3]. 45 
Although they are abundant and potentially important to microbial populations 46 
indigenous to different ecological niches within the human gastrointestinal tract and to host 47 
health, little attention has been paid to bacterial virus-like particle (VLP) assemblages and 48 
their interactions with the gastrointestinal microbiota and/or human host until recently. 49 
Various publications have highlighted the potential importance of bacteriophages in 50 
inflammation states, including Crohn’s disease [4, 5, 6], and as therapeutic agents [7, 8]. 51 
Breitbart et al. [9] conducted the first metagenomic study on dsDNA-containing VLPs 52 
associated with the human faecal virome using a fresh sample from a healthy adult male. On 53 
the basis of previous estimates of gut microbial diversity, Breitbart et al. [9] predicted that 54 
there are two to five times more viral genotypes (~1,200 viral genotypes) present in the 55 
human gastrointestinal microbiota than the number of bacterial species, with the vast majority 56 
of these VLPs representing bacteriophages and prophages. RNA viruses present in human 57 
faeces have been found to be mostly associated with plant viruses, such as Pepper Mild 58 
Mottle Virus, with RNA bacteriophages making a minimal contribution to the diversity of the 59 
intestinal virome [10]. Using frozen samples from four adult female monozygotic twins and 60 
their mothers, Reyes et al. [11] demonstrated that each individual harbours a unique virome 61 
(ssDNA and dsDNA) regardless of their genetic relatedness to another individual, and that 62 
intrapersonal virome diversity is very low, with >95 % of virotypes retained over a one-year 63 
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period (between 71 and 2,773 viral genotypes identified among the samples). More recently, 64 
Minot et al. [12] confirmed inter-individual variation in the virome and, similar to 65 
modulation of the faecal bacteriome by foodstuffs, demonstrated that diet influences host 66 
faecal virome structure. Minot et al. [13] also confirmed the relative stability of an 67 
individual’s virome, monitoring 24 faecal samples from one individual over a 2.5-year 68 
period. 69 
The murine virome has been used to demonstrate enrichment of bacteriophage-70 
encoded, antibiotic-resistance genes (related and unrelated to the drug used) after antibiotic 71 
therapy, with the adaptive capacity of the virome (specifically its bacteriophage component) 72 
suggested to protect gut bacteria, thereby preserving the microbiota’s robustness during 73 
antibiotic stress [14]. 74 
It is clear from the aforementioned studies that the virome–bacteriome community in 75 
the gut is governed by complex and dynamic interactions in health, and that its balance may 76 
be disturbed when under stress, e.g. during antibiotic intervention [14]. Although 77 
metagenomic studies have greatly improved our understanding of the virome associated with 78 
the human and murine gut microbiomes, it has been notable how little bacteriophage 79 
material, and consequently DNA, has been isolated from samples when this information was 80 
included in a publication. Reyes et al. [11] reported the isolation of ~500 ng DNA from 2 to 5 81 
g of frozen faeces, whereas Thurber et al. [15] stated that between 500 and 3000 ng of DNA 82 
could be isolated from 500 g of human faeces, though the publication they cite [9] provides 83 
no information regarding the amount of DNA isolated from the 500 g faecal sample 84 
examined in the original study. In addition, to the best of our knowledge, no attempts have 85 
been made to enumerate bacteriophages in faecal filtrates prior to CsCl purification. The aims 86 
of this study were to develop reliable and effective methods for the recovery and 87 
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characterization of VLPs in human samples, and to apply these methods to human faecal and 88 
caecal samples to demonstrate the methods’ efficiency. 89 
90 
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2. MATERIALS AND METHODS 91 
2.1 Processing of and isolation of VLPs from faecal and caecal samples 92 
Faecal samples were obtained from six healthy adult (2 male, 4 female) donors of 93 
between 23 and 52 years of age, all of whom were members of the Department of Food and 94 
Nutritional Sciences, University of Reading. None of the donors had taken antibiotics, 95 
prebiotics and/or probiotics in the 3 months prior to sampling, and none had any history of 96 
gastrointestinal disorder. All donors gave informed oral consent for their faecal samples to be 97 
used for microbiological analyses. Ethical approval for the collection of caecal effluent from 98 
patients was obtained from St Thomas’ Hospital Research Ethics Committee (06/Q0702/74) 99 
covering Guy’s and St Thomas’ Hospitals and transferred by agreement to London Bridge 100 
Hospital. Where available, clinical information for the colonoscopy patients is given in the 101 
text. Samples were collected at Reading (faeces) or transported from St Thomas’ Hospital 102 
(caecum), and maintained under anaerobic conditions (faeces, MACS1000 anaerobic 103 
workstation, Don Whitley Scientific, gas composition 80 % N2, 10 % H2, 10 % CO2; caecum, 104 
on ice in a gas jar with an anaerobic gas-generating pack; Oxoid Ltd) for a maximum of 2 h 105 
before processing. Caecal samples were collected during routine colonoscopy following 106 
preparation of the bowel with sodium picosulphate and a reduced fibre diet for 3 days. Liquid 107 
residue in the caecum was aspirated via the colonoscope suction channel into a standard 30 108 
ml trap specimen container and immediately transferred to a gas jar.  109 
Faecal homogenates (20 %, w/v, from 25 g of faecal material) were prepared in sterile 110 
TBT [0.1 m filtered prior to autoclaving; 100 mM Tris/HCl, pH 8.0; 100 mM NaCl; 10 mM 111 
MgCl2.6H2O] or sterile 0.5 % ‘Lab-Lemco’/6 % NaCl (LL [16]). Caecal homogenates (20 %, 112 
v/v, from 10 to 30 ml of caecal effluent) were prepared in LL. Faecal and caecal samples 113 
were placed into a filter stomacher bag and homogenized in a Stomacher 400 Lab System 114 
(Seward) for 120 s at low speed. The bag was removed from the stomacher and massaged 115 
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manually to further disperse any large particles remaining in the sample; the sample was then 116 
stomached for a further 120 s. The homogenate was kept on ice for 2 h to allow desorption of 117 
VLPs from solid material, then centrifuged at 11,180 g for 30 min at 10ºC. The supernatant 118 
was transferred to a fresh tube and centrifuged again at 11,180 g for 30 min at 10ºC. 119 
Supernatant [herein referred to as faecal filtrate (FF) for both faecal and caecal samples] was 120 
passed through sterile 0.45 m cellulose acetate filters (Millipore) and the FF was then 121 
collected in a sterile container. An aliquot (10 l) of each of the FFs was examined by 122 
epifluorescence microscopy (EFM) after viral particles had been stained with SYBR Gold 123 
(see below) to confirm that the samples were free of bacteria. 124 
FF prepared in LL was used for enumeration of VLPs in faeces via EFM (see below) 125 
and 1 ml aliquots of FF prepared in TBT were for examination by transmission electron 126 
microscopy (TEM; see below). 127 
Aliquots of FF and LL (two sets of three aliquots of 100 l each: one for aerobic 128 
cultivation, one for anaerobic cultivation) were spread onto Columbia blood agar containing 129 
5 % laked horse blood (Oxoid), and incubated aerobically and anaerobically. Sterility of the 130 
filtrates was confirmed by the absence of microbial growth on plates following incubation for 131 
2 (aerobic) and 5 (anaerobic) days. Sterile brain–heart infusion broth was inoculated with 100 132 
l of FF and LL, and incubated aerobically for 2 days: aliquots (100 l) were spread in 133 
triplicate on plates to confirm sterility of the broth cultures. In addition, 10-ml aliquots of FF 134 
were stored at 4°C for 6 months after collection, and were found to be free of bacteria when 135 
checked (by plating) at monthly intervals. 136 
Poly(ethylene glycol) (PEG; BioUltra, 8000; Sigma) was added to 2  20 ml aliquots 137 
of the LL-prepared 0.45 µm-filtered FFs (final concentration of PEG, 10 %, w/v). The 138 
samples were shaken gently to dissolve the PEG, then left at 4°C for 16 h ([16] used 16 h as 139 
they observed an improved recovery of RNA bacteriophage compared to shorter incubations; 140 
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[17] used 10 h, as they determined this to be longer than the minimum time required to obtain 141 
a constant and stable white layer of viral precipitate). PEG-precipitated VLPs were then 142 
harvested by centrifugation at 4,500 g for 30 min in a swing-out-bucket rotor at 4°C. The 143 
supernatant was removed and the pellet resuspended in 1 ml TBT for pulsed-field gel 144 
electrophoresis (PFGE) or 5 ml TBT for purification of VLPs on a CsCl gradient [15] with 145 
ultracentrifugation performed at 100,000 g for 2 h at 10°C in a fixed-angle Type 50 Ti rotor 146 
(Beckman Coulter). VLPs recovered by CsCl (1.35 and 1.5 g/cm3 fractions) were dialysed 147 
(12,000 Da cut-off) twice against 400 ml sterile TBT, passed through a sterile 0.45 m 148 
cellulose acetate filter and stored at 4°C until DNA was extracted. An aliquot (5 l) of each 149 
of the CsCl-purified samples was viewed using EFM after viral particles had been stained 150 
with SYBR Gold (see below) to confirm that the samples were free of bacteria. 151 
 152 
2.2 Epifluorescence microscopy (EFM) 153 
A combination of the methods of Thurber and Patel [15, 18] was used to prepare FFs 154 
(faecal only) for EFM. VLPs present in FF were not fixed in paraformaldehyde prior to 155 
enumeration, as Wen et al. [19] showed that aldehyde fixation leads to a rapid loss in viral 156 
abundance. The SYBR Gold concentration of 1–5 recommended by [15] did not work with 157 
FFs; therefore, the 400 concentration recommended by [18] for use with planktonic aquatic 158 
samples was used in this study. 159 
The filtration system (see [15] for specifics of the set-up employed), including a 160 
glass-graduated column, for collecting VLPs on filters was cleaned using 5 ml of 0.1 m-161 
filtered, sterile H2O and 5 ml of 0.1 m-filtered ethanol. A sterile pair of flat-tipped forceps 162 
was used to remove a 0.02-m white Anodisc 25 membrane (Whatman) from its box, and the 163 
filter was fitted to the glass frit of the filtration system under a low vacuum [<10 psi (~62 164 
kPa)]. Duplicate 2 ml aliquots of 0.1 m filtered, sterile H2O and 10 l of sterile LL in 2 ml 165 
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0.1 m filtered, sterile H2O were used as negative controls (to assess whether there was any 166 
contamination in the water, the LL, the filter tower or the filter surface) and passed through 167 
filters under low vacuum before any of the FF aliquots were filtered in duplicate. For each 168 
sample, a 10 l aliquot of 0.45 m-filtered FF was added to 2 ml of the 0.1 m filtered, 169 
sterile H2O and the suspension gently mixed. The diluted sample was then introduced into the 170 
filter system with the low vacuum maintained. The liquid was passed through the filter, and 171 
VLPs were collected on the filter. The clip and glass column were carefully removed from 172 
the filtration system and the filter was gently removed from the glass frit (still under 173 
vacuum). While holding the filter with a forceps, the back of the filter was gently blotted dry 174 
on a clean Kimwipe; the filter was then left to dry on a Kimwipe in a sterile Petri dish for 10 175 
min in a dark box. The filtration system was cleaned with 5 ml of 0.1 m-filtered, sterile H2O 176 
and 5 ml of 0.1 m-filtered ethanol, and the next sample processed. 177 
Filters were stained with 100 l droplets of 400 SYBR Gold and dried as described 178 
by [18], prior to being applied in pairs to sterile glass slides. The mountant (20 l per 179 
coverslip) ProLong® Gold antifade reagent (Invitrogen) was added to 25 mm glass coverslips. 180 
Coverslips were picked up with sterile forceps, inverted and placed on the Anodisc filters on 181 
the microscope slides. Slides were then left at room temperature in the dark for 16 h to allow 182 
the antifade to cure. Slides prepared in this manner can be stored at room temperature for 1 183 
week or at 4ºC for 2 months. 184 
Slides were viewed at 1000 magnification under a Nikon Microphot-SA microscope 185 
fitted with a B-2A (blue excitation) filter and attached to a CoolSNAP-Pro MONOCHROME 186 
(Media Cybernetics Inc.) camera. Images were captured using Image-Pro PLUS version 187 
4.5.0.19 (Media Cybernetics Inc.), and VLPs in 25 fields of view were enumerated by eye. 188 
The number of VLPs per millilitre of FF was calculated using the following equation: mean 189 
number of VLPs in 25 fields of view  100  25760.205; where 100 represents taking the 190 
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sample back to per millilitre FF and 25760.205 represents the number of fields of view on a 191 
filter. To give an estimate of the number of VLPs per gram of faeces, results were multiplied 192 
by a factor of 5. The detection limit of the method was 1.03105 VLPs/ml FF or 5.15105 193 
VLPs/g faeces. 194 
 195 
2.3 TEM of FFs (faecal and caecal) 196 
Aliquots (1 ml) of FF prepared in TBT (faeces) or LL (caecum) were used for TEM 197 
analysis within 1 week of collection: these filtrates had not been concentrated using PEG. 198 
Carbon films (~33 mm in size) were floated from mica-sheets into a drop of filtrate (100 199 
l). After an adsorption time of 5–10 min, samples were transferred into a drop of 1 % (v/v) 200 
of EM-grade glutaraldehyde (20 min) and subsequently into a drop of 2 % (w/v) uranyl 201 
acetate for negative staining (1–2 min). After two washes for a few seconds in drops of 202 
distilled water, samples were picked up with 400-mesh copper grids (Plano, Wetzlar, D). 203 
Electron micrographs were taken in a Tecnai 10 transmission electron microscope (FEI 204 
Company, Eindhoven, the Netherlands) at an accelerating voltage of 80 kV. Digital 205 
micrographs were taken with a Megaview G2 CCD camera (Olympus SIS, Münster, 206 
Germany). For estimation of VLP titers on the EM grids, a freshly prepared Lactococcus 207 
lactis bacteriophage preparation with defined titer and unique morphology (i.e. prolate-208 
headed bacteriophage P001 [20]) was added in concentrations of 107 and 108 plaque-forming 209 
units (pfu) per ml to the faecal sample of donor 2 (with highest bacteriophage titer according 210 
to TEM analysis). 211 
 212 
2.4 PFGE 213 
Aliquots (40 l) of PEG-precipitated samples resuspended in 1 ml TBT were used for 214 
PFGE. These were heated at 60 or 75°C as appropriate. An aliquot (25 l) of each heated 215 
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(viscous) suspension and loading dye (5 l) were combined and loaded into wells, which 216 
were sealed with molten agarose. Run conditions for PFGE were as described by Fuhrman et 217 
al. [21]: a 1 % agarose gel (SeaKem LE agarose) was made in 0.5 TBE [250 ml of 5 TBE 218 
buffer (27 g Sigma 7–9, 13.75 g boric acid, 5 ml 0.5 M EDTA, 500 ml of H2O) added to 2.25 219 
l H2O] and a CHEF DR II apparatus (Bio-Rad) was run for 18 h at 6 V and 14°C in 0.5 220 
TBE, with a 1–10 s switch time. Gels were stained with ethidium bromide (5 g/ml) for 20 221 
min and destained in distilled H2O for 10 min, or with 1 SYBR Gold (Molecular Probes) 222 
made in 0.5 TBE. Bands of DNA were visualized under UV light (ethidium bromide) or 223 
using a Dark Reader DR89X Transilluminator (Integrated Scientific Solutions Inc.) (SYBR 224 
Gold). 225 
 226 
2.5 Isolation of DNA from CsCl-purified VLPs 227 
DNA was extracted from 500 l portions of CsCl-purified VLP samples according to 228 
[15]. Prior to extracting DNA from purified VLPs, samples were treated with 20 l of 1 229 
mg/mL DNAse I (from bovine pancreas, 552 Kunitz/mg protein; made in water passed 230 
through a 0.1 m filter prior to autoclaving) for 1 h at 37°C, and were then heated at 80°C for 231 
10 min to inactivate the DNAse prior to DNA extraction. DNA was air-dried and 232 
resuspended in 50 l of TE buffer. Sterility of samples (i.e. absence of bacterial DNA) was 233 
confirmed by negative PCR from samples (10 l) with universal primers [22]. DNA from an 234 
in-house strain of Bifidobacterium longum (4-FAA1; [23]) was used as a positive control; 235 
sterile water was used as the negative control. 236 
237 
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3. RESULTS AND DISCUSSION 238 
3.1 Examination of VLPs in FFs (faeces) by using EFM 239 
Previous studies examining the faecal virome have used 0.22 m filters to prepare 240 
samples [9, 11, 12, 13]. Preliminary work performed with 0.45 m-filtered faecal samples 241 
and 0.45 m-filtered samples originating from in vitro fermentation systems inoculated with 242 
faeces stained with 4,6-diamidino-2-phenylindole (DAPI) and viewed under an 243 
epifluorescence microscope suggested that the abundance of dsDNA VLPs in intestinal 244 
samples was high, and that these particles can be enumerated (unpublished observations). 245 
Contamination by bacteria was not observed in any of these samples, and confirmed by an 246 
absence of cultivable bacteria and no bacteria in TEM analyses, so we decided to continue 247 
using larger-pore filters for processing samples. Klieve & Swain [24] had previously used 248 
0.45 m-filtered samples to characterize VLPs present in rumen contents, and reported no 249 
problems with contamination by bacteria. 250 
To examine the VLPs present in FFs (faeces) by EFM, the method described by [9] 251 
and [15] was used initially. However, it was found that we were unable to visualize many, if 252 
any, VLPs present in the samples using 1–5 SYBR Gold as the DNA/RNA stain. Increasing 253 
the concentration of SYBR Gold to 400, as used by [18] for planktonic aquatic samples, 254 
allowed us to enumerate and detect VLPs present in the FFs prepared from faecal samples of 255 
six donors (Fig. 1 and Fig. 2). The samples were extracted in LL, though the method worked 256 
as well with samples extracted in TBT (data not shown). To determine the relative abundance 257 
of the predominant VLP morphologies in FFs, samples were not concentrated by CsCl 258 
centrifugation (Fig. 1). All FFs were found to be free of bacteria by EFM (Fig. 2), with the 259 
number of VLPs present in samples ranging from 2.4108 to 1.12109 VLPs/ml FF (mean 260 
5.58108 VLPs/ml FF) (equivalent to ~1.2109 to 5.58109 VLPs/g faeces, mean 2.94109). 261 
Lepage et al. [4] enumerated VLPs in gut mucosal samples from 14 healthy individuals and 262 
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19 Crohn’s disease patients and found on average 1.2109 VLPs/biopsy (range 4.4107–263 
1.71010), in agreement with the mean value we present here for faecal VLPs. Of note, 264 
Crohn’s disease patients harboured significantly (P = 0.024) more VLPs than healthy 265 
individuals (2.9109 vs 1.2108 VLPs/biopsy) in the study of Lepage et al. [4]. 266 
It is generally accepted that there are around 10 bacteriophages for every microbial 267 
cell in environmental samples investigated to date [25]. Extrapolating this figure to the gut 268 
microbiota, from fluorescence in situ hybridization studies it is estimated that the faecal 269 
microbiota harbours ~1011 bacteria/g faeces in healthy adults [26]. Consequently, one would 270 
expect the presence of at least 1012 VLPs/g faeces. Enumerating VLPs in faeces via FFs (or 271 
any liquid medium) by EFM is highly subjective as a dot of very intense fluorescence may in 272 
fact represent a cluster of VLPs (Fig. 2), a phenomenon frequently encountered during this 273 
study. Patel et al. [18] stated that, to accurately enumerate VLPs by EFM, micro-adjustments 274 
using the fine focus of the microscope have to be made to ensure that all viruses in a 275 
particular grid-reticle box are counted. We agree with this statement, and furthermore add 276 
that many VLPs have very likely been lost during the preparation and filtering of samples, 277 
either by association with debris in the initial centrifugations or by being caught in the filters 278 
because of clogging or because the VLPs are too big to pass through the pores (e.g. members 279 
of the order Megavirales [27]). Even after centrifugation, the supernatants from several of the 280 
samples, while appearing relatively translucent, were highly viscous (perhaps due to host 281 
mucins) and clogged the 0.45 m filters with less than 2 ml of sample being filtered. 282 
Consequently, the values we provide for the numbers of VLPs in FFs and faecal samples are 283 
a conservative estimate. We believe the true number of VLPs present in faeces to be higher, 284 
possibly between 1010 and 1012 VLPs/g faeces. Lepage et al. [4] determined there to be 1010 285 
VLPs/mm3 tissue in their study of mucosal VLPs. 286 
 287 
  
14 
3.2 Examination of VLP diversity in FFs by the use of TEM 288 
VLPs were readily detected in the TBT-extracted faecal samples from all donors by 289 
TEM. Bacterial cells were never observed in any samples examined by TEM (limit of 290 
detection 106 per ml). It was striking how visibly different/distinct the VLP assemblages were 291 
between the donors, with no two donors sharing the same VLPs, at least on the basis of 292 
morphological appearance (Fig. 3 and Fig. 4; Supplementary Fig. 1). The vast majority of 293 
VLPs present in the samples appear to represent bacteriophages. Donor 1’s VLP assemblage 294 
was predominated by small and large isometric-headed Siphoviridae with various tail length 295 
sizes (approx. 120 nm, 350 nm, 650 nm, or, in one extreme case, 1220 nm), with some small 296 
and large isometric-headed Myoviridae also present (Fig. 3a). Notably, donor 2’s VLP 297 
assemblage was more diverse, predominated by numerous different morphotypes of 298 
Myoviridae with Siphoviridae also present (Fig. 3b). Interestingly, two detached Myoviridae 299 
tails of extreme length (480 nm) and thickness of the sheaths (40 nm) indicated the presence 300 
of giant Myoviridae phages (Fig. 3b). Sime-Ngando et al. [28] have reported isolation of 301 
bacteriophages with tails of 400 nm in length (heads 50–130 nm) from hypersaline lake 302 
samples, though images of these large bacteriophages are unavailable for direct comparison 303 
of the tails’ structures with those found in this study. Donor 2’s faecal sample contained 304 
distinct small isometric-headed Myoviridae phages with uncommon radial fibers (approx 150 305 
nm in length) attached to the capsids (~70 nm diameter) (Fig. 4). These fibers are clearly 306 
extending the 110-nm tails of these phages, suggesting a primary role in bacteriophage 307 
adsorption. This unique bacteriophage morphotype was also documented in low numbers in 308 
Donor 4’s faecal sample (not shown), and in caecal samples L16 (not shown) and L18 309 
(Supplementary Fig. 2d). Fig. 4 also illustrates the apparent clustering of Myoviridae phages 310 
in samples. VLPs of various morphotypes derived from Donors 3, 4, 5, and 6 are shown in 311 
Supplementary Figure 1a–d. “Zeppelin”-like VLPs of constant thickness (56 nm) but 312 
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different lengths (370–630 nm) were detected in Donor 5 (Supplementary Fig. 1c) and Donor 313 
6’s samples (Supplementary Fig. 1d). Donor 6’s sample was predominated by these 314 
“zeppelin”-like VLPs, with only a few bacteriophages detected. Sime-Ngando et al. [28] 315 
reported the presence of rods of up to 22–24 1000 nm: similar to the ‘zeppelins’ identified 316 
in the present study, these rods had no visible internal or external structures. The largest 317 
Myoviridae phages found in this study were documented for the sample of Donor 5 318 
(Supplementary Fig. 1c), with the phages having prolate heads of 150 × 115 nm and tails of 319 
400 nm in length. The sample from Donor 6 did not reveal the same level of diversity as seen 320 
for the other faecal samples and the reason for this is not known (Supplementary Fig. 1d). 321 
Enumeration of VLPs in the sample of Donor 2 (highest number of VLPs as detected by 322 
TEM) demonstrated there to be approx. 5×107 VLPs/ml FF. 323 
For the majority of the caecal samples, a lower extent of viral biodiversity was 324 
documented. Sample L10 (no clinical data) was unique, containing exclusively small 325 
isometric-headed Podoviridae (50 nm diameter) and ~20-nm long appendages (Fig. 5b). 326 
Samples L08 (healthy) (Fig. 5a), and L02 and L03 (both IBD) (Suppl. Fig. 5b, c) appeared to 327 
exclusively contain Myoviridae phages. The greatest extent of morphological variation and 328 
the highest bacteriophage numbers were seen in caecal samples L16 (no clinical data) and 329 
L17 (no clinical data) (Fig. 5c, d) and – to a lesser extent – in samples L01 (diverticulosis) 330 
and L18 (no clinical data) (Supplementary Fig. 2a, d). A new type of a giant Myoviridae 331 
bacteriophage was exclusively found in sample L16 (Fig. 5c) with isometric heads of 125 nm 332 
in diameter, with tails of 340 nm in length and unique “curled” tail fibers of ~70-nm in 333 
length.  334 
Lepage et al. [4] demonstrated that gut mucosal samples were predominated by 335 
morphotypes consistent with Siphoviridae, Myoviridae and Podoviridae, and that each 336 
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individual appeared to be colonized by one dominant bacteriophage family. Our TEM results 337 
for faecal and caecal VLP assemblages are consistent with these results. 338 
 339 
3.3 PFGE of VLPs present in FFs 340 
It was clear from the EFM and TEM analyses that, based on the number of VLPs 341 
present in our samples, it should be possible to isolate large amounts of VLP-derived DNA 342 
from faeces. Attempts to recover abundant VLP DNA from samples using the centrifugation 343 
method of Thurber et al. [15], and which was used by [9] and [11] to isolate VLP DNA from 344 
faecal samples, proved disappointing in terms of the recovered DNA yield. However, 345 
increasing the centrifugation speed to 100,000 g, routinely used in the laboratory to purify 346 
lactococcal bacteriophages for preparation of high-quality DNA and used by Kulikov et al. 347 
[29] to recover bacteriophages from horse faeces, markedly improved recovery of faecal 348 
VLPs. 349 
To concentrate VLPs from 20-ml quantities of FF so that they could be applied to 350 
CsCl gradients in 5 ml aliquots, it was decided to use PEG precipitation. This method of 351 
recovery has previously been used with, for example, marine samples and faecal samples to 352 
improve detection of F-specific coliphages in faecal material [16, 17], and allows large 353 
starting volumes of sample to be used for recovering VLPs from human faeces. The method 354 
can be scaled easily so that the VLPs from larger volumes of FF are precipitated for 355 
collection by centrifugation: we used 20 ml of FF from each donor here to demonstrate the 356 
efficacy of the method, but the entire FF derived for each donor’s 25 g of starting material 357 
could have been used for PEG precipitation of VLPs. 358 
PEG-precipitated samples resuspended in 1 ml TBT were examined using PFGE. 359 
Aliquots (40 l) of the resuspended pellets were heated at 60°C [9] or 75°C ([24] used this 360 
temperature to inactivate nucleases) before PFGE. Profiles containing one or more bands 361 
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were observed for samples from all donors (Fig. 6). Following treatment at 60ºC, Donor 1’s 362 
sample produced a faint band at 105 kb, with this band being more prominent following 363 
sample treatment at 75ºC; at the higher temperature, bands were also observed at 135 kb and 364 
just below 48.5 kb, with the most prominent band at 79 kb. Donor 2’s 60ºC-treated sample 365 
produced a profile with a faint smear and a thin band at 84 kb; with the 75ºC-treated sample, 366 
the smear was more pronounced, with a thick band observed between 75 and 84 kb. Similar 367 
to Donor 2, the smear in Donor 4’s sample became more pronounced following treatment at 368 
the higher temperature. For Donor 3’s 60ºC-treated sample, two strong bands (at 66 and 97 369 
kb) were observed; in the 75ºC-treated samples, bands were observed at 57 kb, 75 kb and 97 370 
kb. The profile of Donor 5 was most affected by changing the temperature at which samples 371 
were treated prior to loading on the gel: the 60ºC-treated sample had three bands visible 372 
(most prominent at 100 kb, fainter bands at 48.5 kb and 66 kb), whereas the 75ºC-treated 373 
sample had these three bands with at least another 8 bands visible between 48.5 and 97.0 kb. 374 
Donor 6’s sample had a faint band just below 48.5 kb after heating at 60ºC, whereas the 375 
sample heated at the higher temperature produced two prominent bands that were smaller 376 
than 48.5 kb. The results from the gel were reproducible (triplicate gels run; data not shown). 377 
It is unsurprising that heating at 75ºC produced more complex banding patterns, as we would 378 
expect the higher temperature to disassemble (some of) the capsids of VLPs resistant to 379 
heating at 60ºC, thereby releasing packaged DNA. 380 
Using this method, it was possible to visualize VLP DNA when stained with SYBR 381 
Gold (Fig. 6) or ethidium bromide (Supplementary Fig. 3). It was clear that increasing the 382 
temperature at which the samples were heated prior to loading onto the gel revealed greater 383 
diversity in the samples, and that each individual harboured a unique VLP assemblage (Fig. 384 
4). This is in agreement with the findings of the metagenomic studies of [11] and [12]. The 385 
sample from Donor 6 did not reveal the same level of diversity as seen for the other donors, 386 
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in agreement with the results shown by TEM (Supplementary Fig. 1d). This donor’s sample 387 
was predominated by “zeppelin”-like VLPs that may not have released their nucleid acids by 388 
the conditions employed here. 389 
Heating PEG-precipitated samples allowed us to generate PFGE images that 390 
demonstrated that each individual harbours a unique VLP assemblage, and encouraged us to 391 
continue with studies to improve recovery of VLP DNA from human faeces. It also showed 392 
that our method of recovery of VLPs present in faeces was superior to that used previously 393 
by [9] to generate a viral assemblage fingerprint. In that study, the authors stated that the 394 
limited amount of DNA recovered using tangential flow filtration with a 500 g faecal sample 395 
from a 33-year-old made it necessary to enhance the sample bands on the gel relative to the 396 
ladder. In contrast, no enhancement of the bands detected by SYBR Gold (Fig. 6) or ethidium 397 
bromide (Supplementary Fig. 3) was required using the methodology described herein, 398 
although SYBR Gold was, as expected, far more sensitive than ethidium bromide. PEG 399 
precipitation of VLPs present in 20 ml of FF, as used in this study, equates to the extraction 400 
of VLPs from ~4 g faeces (sample losses are seen during filtration, and vary from donor to 401 
donor due to the differences in viscosity of faecal supernatant obtained after removal of most 402 
bacteria and debris from samples after centrifugation), with 50 l of the resuspended PEG 403 
precipitate representing VLPs isolated from ~200 mg of faeces. 404 
The current study used a crude method of extracting DNA for PFGE. Using the 405 
method of Rohozinski et al. [30], in which VLPs are embedded in agarose blocks, with CsCl-406 
purified VLPs prior to heating may allow better ‘fingerprinting’ of VLPs in faecal samples. 407 
This could, for example, be used as an inexpensive means of determining the effect of 408 
freeze–thawing faecal samples prior to the recovery of VLPs from faecal samples. All of the 409 
metagenomic studies conducted to date on the human faecal virome have used samples that 410 
have been frozen prior to recovery of VLPs from samples. 411 
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 412 
3.4 Isolation of high-quality DNA from FFs 413 
Reyes et al. [11] and Thurber et al. [15] (based on the work of [9]) have reported 414 
recovery of ~500 ng (from 2–5 g of frozen faeces) and 500–3000 ng (from 500 g of fresh 415 
faeces), respectively. The method of Reyes et al. [11] is closest to that presented herein for 416 
the recovery of VLPs from faeces [i.e. they hand-filtered samples, whereas Breitbart et al. [9] 417 
used tangential flow filtration to process their sample]. As stated above, 20 ml of FF equates 418 
to ~4 g faeces. We processed 500 l portions of 3.5–4 ml CsCl-purified VLPs for DNA 419 
extraction, and resuspended the DNA in 50 l of TE (Fig. 7). If we had processed the entire 420 
PEG-precipitated, CsCl-purified VLP sample for each donor, we would have recovered 421 
between ~1000 and 1800 ng from ~4 g of faeces (theoretically ~6000–11000 ng from 25 g of 422 
faeces). This increase in recovery of DNA is thought to be mainly due to the use of 0.45 m 423 
filters rather than 0.22 m filters to process samples, supported by our observation that 424 
passing FFs through 0.22 m filters led to VLP counts by EFM that were approximately half 425 
of those of the 0.45 m-filtered samples. Increasing filter size and using PEG precipitation to 426 
increase the volume of sample that can be processed would allow greater sampling of the 427 
faecal virome in future metagenomics studies. 428 
In addition to demonstrating the utility of the method with faecal samples, we have 429 
successfully isolated VLP DNA from human caecal effluent (Fig. 7). For each of the samples, 430 
20 ml of 0.45 m-filtered caecal filtrate prepared in LL was PEG-precipitated, with the VLPs 431 
then purified on CsCl gradients. These 20-ml aliquots equated to ~4 ml caecal effluent from 432 
each of the three samples examined. We started with 30, 30 and 10 ml, respectively, of 433 
effluent from caecal samples L07 (healthy), L08 (no clinical data) and L10 (no clinical data). 434 
Therefore, if the filtrate from entire homogenates of these samples had been processed, we 435 
would have expected to isolate between ~600 and 8000 ng VLP DNA from caecal effluent. 436 
  
20 
Consequently, it should be possible to conduct metagenomics studies of the VLP 437 
assemblages associated with the human caecum using the methods described herein. 438 
 439 
3.5 Conclusions 440 
We have presented a series of methods for enumerating and characterizing VLPs 441 
present in human faecal and caecal samples. On the basis of enumeration of VLPs using 442 
EFM, there are ~108 VLPs/ml FF, with faeces thought contain up to 1012 VLPs per gram of 443 
sample. TEM analysis of faecal VLPs indicates that an individual is colonized by one 444 
dominant bacteriophage family, with Myoviridae and Siphoviridae representing the main 445 
families of bacteriophage detected in faeces. PFGE analysis of PEG-concentrated samples 446 
has demonstrated that each individual harbours a unique VLP population, and that the 447 
temperature at which samples are treated greatly affects diversity observed. Using 0.45 m 448 
filters to prepare samples, it is possible to isolate twice as much DNA as reported previously 449 
from ~4 g of faeces. The inclusion of PEG precipitation in the methodology means that VLPs 450 
from large volumes of FF can be concentrated, allowing recovery of microgram quantities of 451 
VLP DNA from faecal samples. In addition, PEG precipitation and CsCl purification can be 452 
used to recover VLPs from human caecal samples, with nanogram quantities of VLP DNA 453 
being recovered from the processed samples. 454 
 455 
 456 
457 
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Fig. 1. Number of VLPs detected in FFs by using EFM. Values are shown as mean + SD (n = 538 
2 per donor). Passing samples through a 0.22 m filter reduced the number of VLPs present 539 
in samples by approximately half (data not shown). White bars, per ml FF (faeces); grey bars, 540 
per g faeces. 541 
 542 
543 
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Fig. 2. Image showing faecal VLPs as they appear under an epifluorescence microscope 544 
(×1000 magnification). Bacteriophages appear as ‘pinpricks’ of light when stained with 545 
SYBR Gold. The brightest ‘pinpricks’ (black arrows) represent clusters of up to 30 VLPs. 546 
The black dot (shown in the white circle) on the images is due to a scratch on the microscope 547 
lens. (a) Contamination on filter, which gives an idea of the size and appearance of a 548 
bacterium in comparison with VLPs. (b) Negative control, 0.1 m-filtered, autoclaved H2O. 549 
(c) Negative control, sterile 0.5 % ‘Lab-Lemco’/6 % NaCl. (d) Donor 1, 0.22 m-filtered 550 
sample; (e) Donor 1 0.45 m-filtered sample. (f) Donor 2, 0.22 m-filtered sample; (g) 551 
Donor 2, 0.45 m-filtered sample. Scale bar, 10 m. 552 
553 
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Fig. 3. Transmission electron micrographs revealing the diversity of VLPs found in faeces. 554 
(a) Donor 1 (female, 41 years) and (b) Donor 2 (female, 36 years) after extraction of VLPs in 555 
TBT buffer. 556 
557 
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Fig. 4. Transmission electron micrographs of VLPs found in faeces of Donor 2 (female, 36 558 
years) after extraction of VLPs in TBT buffer showing Myoviridae phages with radial 559 
whiskers attached to the capsids (top) and clusters of Myoviridae phages adsorbing to 560 
membrane vesicle material (bottom). 561 
562 
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Fig. 5. Transmission electron micrographs revealing the diversity of VLPs found in caecal 563 
effluents. Sample (a) L08, (b) L10, (c) L16 and (d) L17 after extraction of VLPs in LL. No 564 
clinical data were available for these individuals. 565 
566 
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Fig. 6. Use of PFGE to examine VLP populations in PEG-precipitated FFs (faeces), and 567 
demonstration that increasing the temperature at which samples are heated prior to loading 568 
onto the gel can affect the diversity uncovered. The gel was stained with SYBR Gold and 569 
visualized as described in Methods. This is a crude (but inexpensive) method of examining 570 
VLP populations in human faeces, and demonstrates that each individual harbours a unique 571 
VLP profile. Ladder, lambda ladder (#340; New England Biolabs). 572 
573 
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Fig. 7. Isolation of high-quality DNA from CsCl-purified samples of human gastrointestinal 574 
VLPs. VLP preparations were CsCl-purified and DNA extracted as described in Methods. 575 
Aliquots (10 l) of sample were run on a 0.8 % agarose gel at 90 V for 30 min. Lane 1, 576 
molecular size ladder; lane 2, KPLN1 positive control (a bacteriophage isolated from the 577 
human caecum that infects Klebsiella pneumoniae subsp. pneumoniae K2 strains; L. Hoyles, 578 
unpublished data), 63 ng DNA/l; lane 3, VLP extract from faeces of Donor 4, 3.1 ng 579 
DNA/l; lane 4, VLP extract from faeces of Donor 3, 4.5 ng DNA/l; lane 5, VLP extract 580 
from caecal sample L07 (healthy), 0.2 ng DNA/l; lane 6, VLP extract from caecal sample 581 
L08 (no clinical data), 2.7 ng DNA/l; lane 7, VLP extract from caecal sample L10 (no 582 
clinical data), 3.8 ng DNA/l. The two black arrows highlight the presence of RNA in the 583 
sample from Donor 3, confirmed by treating the CsCl-purified sample with 20 l of 1 mg/mL 584 
RNAse A (bovine pancreas, ≥70 Kunitz/mg protein, prepared in 0.1 m-filtered, sterile H2O) 585 
with the DNAse in a second DNA extraction (not shown). VLPs and DNA were extracted 586 
from human caecum samples (1:4 LL, v/v) as described in Methods as part of a study 587 
examining the microbiota associated with the human caecum (L. Hoyles, unpublished data). 588 
With the exception of the sample in lane 5, DNA visible to the naked eye was extracted from 589 
all samples of gastrointestinal origin. 590 
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